Evaluation of 4 different auto-adjusting positive airway pressure (APAP) devices: a cross-over trial versus a reference APAP (418P)

D. Alfandary (Corbeil Essonnes, France)

Source: Annual Congress 2005 - OSAS control of ventilation, guidelines, doctors and patients
Session: OSAS control of ventilation, guidelines, doctors and patients
Session type: Thematic Poster Session
Number: 518
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Alfandary (Corbeil Essonnes, France). Evaluation of 4 different auto-adjusting positive airway pressure (APAP) devices: a cross-over trial versus a reference APAP (418P). Eur Respir J 2005; 26: Suppl. 49, 518

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patient evaluation of three auto-adjusting positive airway pressure (APAP) devices
Source: Eur Respir J 2004; 24: Suppl. 48, 566s
Year: 2004

Fixed pressure (FP) versus auto-adjusting continuous positive airway pressure (autoCPAP): Comparison of efficacy in reducing blood pressure, a randomized controlled trial
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013

The clinical efficacy and comfort of modified automatic positive airway pressure (APAP) mode compared with continuous positive airway presure (CPAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

Effect of continuous positive airway pressure (CPAP) on resistant hypertension. A randomised, controlled study
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Randomized controlled crossover trial comparing CPAP with an autoCPAP device combined with pressure reduction during exhalation (autoC-FlexÔ)
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device
Source: Eur Respir J 2004; 24: Suppl. 48, 406s
Year: 2004

Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011

Randomized study of an auto-titration device (Somnoset®) vs. manual CPAP titration
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


The effect of high dose N-acetylcysteine (1200mg daily) on airway function and airway trapping in COPD patients — A double blinded randomized placebo controlled trial
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012


A randomised, 4-way crossover study to examine the lung pharmacodynamic effects of single inhaled doses of tiotropium (18 μg), salmeterol (50 μg), tiotropium (18 μg) and salmeterol (50 μg) and placebo using whole body plethysmography in healthy subjects
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Negative pressure ventilation (NPV) by iron lung versus noninvasive positive pressure ventilation (NPPV) in the treatment of acute respiratory failure (ARF) in COPD patients: a prospective randomized multicentre study
Source: Eur Respir J 2001; 18: Suppl. 33, 185s
Year: 2001

Randomized, double blind, double dummy, placebo-controlled trial designed for comparing the effectiveness of formoterol (Foradil®) Aerolizer® and ipatropium bromide plus nebulized fenoterol (Berodual®) in asthma patients with ages ranging between 5 and 12 years who suffer acute asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Validation of a sham bi-level positive airway pressure device for placebo-controlled studies
Source: Eur Respir J 2002; 20: Suppl. 38, 625s
Year: 2002

Negative pressure ventilation (NPV) by iron lung versus conventional mechanical ventilation (CMV) in the treatment of acute respiratory failure (ARF) in COPD patients: a prospective randomized controlled study
Source: Eur Respir J 2001; 18: Suppl. 33, 185s
Year: 2001

PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Randomized clinical trial (RCT) comparing formoterol vs. salbutamol plus ipratropium bromide in the treatment of acute asthma exacerbation (AE) at emergency room (ER)
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005

Randomised controlled trial of nasal continuous positive airways pressure (CPAP) in severe bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 27s
Year: 2005

Acute effects of tiotropium (T), salmeterol (S) and formoterol (F) on arterial blood gases (ABGs) in patients with stable COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Mometasone/indacaterol (MF/IND) and mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) and FLU/SAL+tiotropium (TIO) in patients with inadequately controlled asthma: data from the PLATINUM program
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009